4//SEC Filing
Farquharson Andrew 4
Accession 0000950170-24-066582
CIK 0001856725other
Filed
May 29, 8:00 PM ET
Accepted
May 30, 4:10 PM ET
Size
5.5 KB
Accession
0000950170-24-066582
Insider Transaction Report
Form 4
Farquharson Andrew
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-29+50,000→ 50,000 totalExercise: $5.00Exp: 2034-05-28→ Class A Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in full on the first anniversary of the date of grant, subject to the recipient's Continuous Service (as defined in the Company's 2021 Equity Incentive Plan) through such vesting date; provided that, if earlier, the shares subject to the option will vest in full upon the occurrence of either of the following events: the Company's next annual stockholder meeting or a Change in Control (as defined in the Company's 2021 Equity Incentive Plan).
Documents
Issuer
Rani Therapeutics Holdings, Inc.
CIK 0001856725
Entity typeother
Related Parties
1- filerCIK 0001865699
Filing Metadata
- Form type
- 4
- Filed
- May 29, 8:00 PM ET
- Accepted
- May 30, 4:10 PM ET
- Size
- 5.5 KB